Literature DB >> 20640484

The changed ultrastructure of fibrin networks during use of oral contraception and hormone replacement.

Etheresia Pretorius1, Hester Magdalena Oberholzer, Wendy Jeannette van der Spuy, Johannes Henricus Meiring.   

Abstract

Contraceptives and hormone replacement have been extensively used since the late 1950s. However, adverse effects are common and include an increased risk of cardiovascular diseases, including thrombo-embolic diseases. Previous research has shown that ultrastructure of fibrin networks may provide great insight regarding the thrombotic potential of patients. The current study investigates the scanning electron microscopy (SEM) ultrastructure of fibrin networks of individuals using oral contraceptive therapy as well as individuals using hormone replacement. We compare micrographs of these two groups with micrographs of young, healthy individuals not using oral contraception. Platelet rich plasma and thrombin was used to prepare the fibrin clots. Here we show that during contraceptive and hormone replacement use, a netted fibrin layer forms. We suggest that oestradiol use causes fibrin network changes and these changes can be seen using SEM technology. These changes may provide further evidence regarding the increased occurrence of thrombotic events during contraceptive and hormone replacement therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640484     DOI: 10.1007/s11239-010-0502-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  11 in total

1.  Smoking and coagulation: the sticky fibrin phenomenon.

Authors:  Etheresia Pretorius; Hester Magdalena Oberholzer; Wendy Jeannette van der Spuy; Johannes Henricus Meiring
Journal:  Ultrastruct Pathol       Date:  2010-08       Impact factor: 1.094

2.  Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.

Authors:  Julia V Johnson; Jane Lowell; Gary J Badger; Jan Rosing; Svetlana Tchaikovski; Mary Cushman
Journal:  Obstet Gynecol       Date:  2008-02       Impact factor: 7.661

Review 3.  Epidemiology of hormone-related venous thromboembolism.

Authors:  Saskia Middeldorp
Journal:  Thromb Res       Date:  2009       Impact factor: 3.944

Review 4.  Risk of cardiovascular diseases with oral contraceptives.

Authors:  A Nessa; S A Latif; N I Siddiqui
Journal:  Mymensingh Med J       Date:  2006-07

5.  The role of platelet and fibrin ultrastructure in identifying disease patterns.

Authors:  E Pretorius
Journal:  Pathophysiol Haemost Thromb       Date:  2009-12-09

6.  Ultrastructural changes in platelet aggregates of HIV patients: a scanning electron microscopy study.

Authors:  Etheresia Pretorius; Helena M Oberholzer; Eureke Smit; Elmarie Steyn; Sharon Briedenhann; Carl R Franz
Journal:  Ultrastruct Pathol       Date:  2008 May-Jun       Impact factor: 1.094

Review 7.  Venous thromboembolism in women.

Authors:  Suman Rathbun
Journal:  Vasc Med       Date:  2008-08       Impact factor: 3.239

Review 8.  Hormone therapy and risk of venous thromboembolism among postmenopausal women.

Authors:  M Canonico; P-Y Scarabin
Journal:  Climacteric       Date:  2009       Impact factor: 3.005

Review 9.  Oral contraceptives and the risk of venous thromboembolism.

Authors:  Saskia Middeldorp
Journal:  Gend Med       Date:  2005

Review 10.  Oral contraception and thrombophilia.

Authors:  Dorit Blickstein; Isaac Blickstein
Journal:  Curr Opin Obstet Gynecol       Date:  2007-08       Impact factor: 1.927

View more
  1 in total

1.  Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).

Authors:  Etheresia Pretorius; Chantelle Venter; Gert Jacobus Laubscher; Maritha J Kotze; Sunday O Oladejo; Liam R Watson; Kanshu Rajaratnam; Bruce W Watson; Douglas B Kell
Journal:  Cardiovasc Diabetol       Date:  2022-08-06       Impact factor: 8.949

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.